Dov A. Goldstein Md.

Companies

• BioAge Labs, Inc.Chief financial officer Sep 25, 2024 to now¹
• Coya Therapeutics, Inc.Board member Dec 28, 2022 to now²
• Gain Therapeutics, Inc.Board member Mar 17, 2021 to now³
• NeuBase Therapeutics, Inc.Board member Jul 16, 2019 to Sep 12, 2022⁴
• ADMA Biologics (United States)Board member Feb 15, 2012 to May 1, 2020⁵
• Esperion TherapeuticsBoard member Jun 25, 2013 to Jun 8, 2018⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BLBioAge Labs, Inc. BIOA36,575 shares⁷$180.9K at $4.95Apr 23, 2026
• CTCoya Therapeutics, Inc. COYA27,557 shares⁸$117.9K at $4.28Aug 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 23, 2026Exercised options 3,542 shares at $4.38 of BioAge Labs, Inc.⁷
• Mar 1, 2026Exercised options 3,542 shares at $4.38 of BioAge Labs, Inc.⁹
• Feb 1, 2026Exercised options 3,541 shares at $4.38 of BioAge Labs, Inc.¹⁰
• Jan 16, 2026Exercised options 3,542 shares at $4.38 of BioAge Labs, Inc.¹¹
• Jan 13, 2026Sold 1,923 shares at $21.08 of BioAge Labs, Inc.¹²
• Jan 13, 2026Sold 11,663 shares at $20.54 of BioAge Labs, Inc.¹²
• Jan 13, 2026Sold 4,440 shares at $19.45 of BioAge Labs, Inc.¹²
• Jan 13, 2026Sold 8,974 shares at $18.43 of BioAge Labs, Inc.¹²
• Jan 13, 2026Exercised options 27,000 shares at $8.39 of BioAge Labs, Inc.¹²
• Aug 18, 2025Exercised options 17,557 shares at $1.09 of Coya Therapeutics, Inc.⁸
• Jan 3, 2023Bought 10,000 shares of Coya Therapeutics, Inc.¹³